| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/09/1996 | US5534254 Biosynthetic binding proteins for immuno-targeting |
| 07/09/1996 | US5534250 Polymers containing diester units |
| 07/09/1996 | US5534241 Micelles, liposomes; use as diagnostic and therapeutic agents; contrast agents for magnetic resonance imaging |
| 07/09/1996 | US5534240 Unchelated manganese composition for MRI of the gastrointestinal tract |
| 07/03/1996 | EP0719340A1 Cloned glutamic acid decarboxylase |
| 07/03/1996 | EP0719274A1 Method for dosing therapeutic compounds |
| 07/03/1996 | EP0719273A1 Nucleotide analogs |
| 07/03/1996 | EP0719254A1 Method for the preparation of high purity substituted benz e]indoles and the alkaline salts thereof |
| 07/03/1996 | EP0719157A1 Contrasting agents for ultrasonic diagnosis |
| 07/03/1996 | EP0417160B1 Method for hla dp typing |
| 07/03/1996 | CN1125906A Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 07/03/1996 | CN1125905A 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 07/02/1996 | US5531980 Stable microbubbles suspensions injectable into living organisms |
| 07/02/1996 | US5531979 X-ray contrast composition |
| 07/02/1996 | US5531978 Aminopolycarboxylic acids and derivatives thereof |
| 06/27/1996 | WO1996019566A1 E2 binding proteins |
| 06/27/1996 | WO1996019487A1 Organobismuth derivatives and process for producing the same |
| 06/27/1996 | WO1996019447A1 Disubstituted p-fluorobenzolsulfonamides and their use in nmr diagnostics |
| 06/27/1996 | WO1996019236A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 06/27/1996 | DE4447389A1 Disubstituierte p-Fluorbenzolsulfonamide Disubstituted p-Fluorbenzolsulfonamide |
| 06/27/1996 | CA2208341A1 Disubstituted p-fluorobenzenesulfonamides |
| 06/27/1996 | CA2208211A1 E2-binding proteins |
| 06/26/1996 | EP0718309A1 Antigens and antibodies for the detection of collagen I |
| 06/26/1996 | EP0717849A1 Assay systems using the cntf signal transduction pathway |
| 06/26/1996 | EP0717737A1 Chelants as contrast enhancing agents |
| 06/26/1996 | EP0717658A1 Polymeric surfactant-encapsulated microbubbles and their use in ultrasound imaging |
| 06/26/1996 | EP0717639A1 Polyamino paramagnetic chelates which contain both phosphonate and non-phosphonate moieties for mri |
| 06/26/1996 | EP0717635A1 Methods for regulating gastrointestinal motility |
| 06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
| 06/26/1996 | EP0717617A1 New active principle-containing microparticles, agents containing the same, their use for the ultrasonically controlled release of active principles, and process for preparing the same |
| 06/26/1996 | EP0660714A4 Novel liposomal drug delivery systems. |
| 06/26/1996 | EP0616508A4 Gas filled liposomes and their use as ultrasonic contrast agents. |
| 06/26/1996 | EP0474642B1 Chelants |
| 06/26/1996 | CN1125402A Potassium channel blocking compounds and their use |
| 06/26/1996 | CN1125394A Novel therapeutic drug delivery systems |
| 06/26/1996 | CN1125393A Novel therapeutic delivery systems |
| 06/26/1996 | CN1125389A Methods of preparing gas and gaseous precursor-filled microspheres |
| 06/25/1996 | US5530179 Transgenic immunodeficient animal models |
| 06/25/1996 | US5530140 Triarylmethyl radicals constrast agent for magnetic resonance imaging |
| 06/25/1996 | US5530096 Diagnosis and therapy of tumors, autoimmune diseases |
| 06/25/1996 | US5529766 Microbubbles comprising protein capable of formation of gas containing microbubbles, protein is crosslinked with crosslinkig grouping contains biodegradable linkages |
| 06/25/1996 | US5529066 For detecting a constituent or a condition in a patient |
| 06/20/1996 | WO1996018421A1 Anticancer drug with a cytostatic and a contrasting agent |
| 06/20/1996 | WO1996018420A1 Method of storage of ultrasonic gas suspensions |
| 06/20/1996 | WO1996018415A1 Selective and non-invasive visualization or treatment of vasculature |
| 06/20/1996 | WO1996018388A2 Cross-linked microparticles and their use as therapeutic vehicles |
| 06/20/1996 | WO1996018291A1 Helicobacter pylori-colonized mongolian gerbil, process for preparation thereof, medium for separating helicobacter pylori, and method of screening anti-helicobacter pylori-active substance by using the same |
| 06/20/1996 | WO1996015234A3 Lipid-splitting enzyme |
| 06/20/1996 | CA2182805A1 Helicobacter pylori-colonized mongolian gerbil, process for preparation thereof, medium for separating helicobacter pylori, and method of screening anti-helicobacter pylori-activesubstance by using the same |
| 06/19/1996 | EP0523116B1 Use of superparamagnetic particles for magnetometric analysis (SQUID) |
| 06/19/1996 | EP0381742B1 Receptor mediated endocytosis type mri contrast agents |
| 06/19/1996 | CN1124779A Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of IRF-1-spectific RNA in biopsy samples |
| 06/19/1996 | CN1124731A Calcium complex of 4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedioic acid and is salts, pharmaceutical agents containing these complexes |
| 06/18/1996 | US5527962 Fluoropolymer with perfluoroalkyl mercaptan end group as carrier for drug delivery |
| 06/18/1996 | US5527926 Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures |
| 06/18/1996 | US5527771 Methods and Compositions for treatment of diabetes mellitus, hypoglycemia & other conditions |
| 06/18/1996 | US5527713 Consisting of t-cell specific antibodies covalently bound to amine groups present on water soluble aminodextran |
| 06/18/1996 | US5527522 Hydroxy-aryl metal chelates for diagnostic NMR imaging |
| 06/18/1996 | US5527521 Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications |
| 06/18/1996 | US5526816 Ultrasonic spectral contrast imaging |
| 06/13/1996 | WO1996017629A1 Use of additives in contrast mediums to improve imaging |
| 06/13/1996 | WO1996017628A1 In-vivo diagnostic process by near infrared radiation |
| 06/13/1996 | DE4446694A1 Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung Use of additives to contrast agents for improving the imaging |
| 06/13/1996 | DE4445076A1 Oligo:nucleotide conjugate with metal chelating residue for NMR diagnosis |
| 06/13/1996 | DE4445065A1 Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung A method for in vivo diagnosis using NIR radiation |
| 06/13/1996 | CA2207025A1 Use of additives in contrast media to improve imaging |
| 06/12/1996 | EP0716091A1 Tris(substituted phenyl)bismuth derivative |
| 06/12/1996 | EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity |
| 06/12/1996 | CN1124446A Method and apparatus for diagnosing erectile dysfunction |
| 06/11/1996 | US5525338 Detection and therapy of lesions with biotin/avidin conjugates |
| 06/11/1996 | US5525334 Method for vascular embolization |
| 06/11/1996 | US5525328 Administering before x-ray exposure |
| 06/11/1996 | US5525327 Polymeric x-ray contrast compositions containing iodinated polymeric beads and microcrystaline cellulose |
| 06/11/1996 | US5525326 Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
| 06/11/1996 | US5525325 Form metal complexes active as photosensitizers which are stable and water soluble |
| 06/11/1996 | US5525324 Organic silicon contrast agents and methods of use |
| 06/06/1996 | WO1996016929A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions |
| 06/06/1996 | WO1996016928A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy |
| 06/06/1996 | WO1996016679A1 Paramagnetic complexes of n-alkyl-n-hydroxylamides of organic acids and emulsions containing same for magnetic resonance imaging (mri) |
| 06/06/1996 | WO1996016678A1 Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts |
| 06/06/1996 | WO1996016677A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
| 06/06/1996 | WO1996016588A2 Method and apparatus for diagnosing capillary leak |
| 06/06/1996 | CA2206576A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents that contain these complexes and their use in diagnosis and therapy |
| 06/06/1996 | CA2206558A1 Use of metal complexes as x-ray diagnostic agents for the liver and gallbladder |
| 06/06/1996 | CA2206522A1 Novel, multiply substituted dtpa derivatives and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of complexing agents and complexes and process for the production of pharmaceutical agents |
| 06/06/1996 | CA2206397A1 Use of metal complexes as liver and gall bladder x-ray diagnostic agentsin computer tomography |
| 06/06/1996 | CA2205232A1 Paramagnetic complexes of n-alkyl-n-hydroxylamides of organic acids and emulsions containing same for magnetic resonance imaging (mri) |
| 06/05/1996 | EP0715170A2 Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements |
| 06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
| 06/05/1996 | EP0714879A1 Biphenyl iodinated derivatives and their diagnostic use |
| 06/05/1996 | EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 06/05/1996 | EP0714405A1 Therapeutic and diagnostic agents for amyloidosis |
| 06/05/1996 | EP0714402A1 Polymer modification |
| 06/05/1996 | EP0714298A1 Photosensitizers |
| 06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 06/05/1996 | CN1123914A Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoblobin measurements |
| 06/04/1996 | US5523402 Tripyridyl macrocyclic compounds |
| 06/04/1996 | US5522327 Balanced pressure solid fuel heating unit |
| 06/03/1996 | CA2149580A1 Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements |
| 05/30/1996 | WO1996015815A1 Microcapsules, method of making and their use |